VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
NTRNutrien Ltd.
$62.86$30.2B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

NTR logoNutrien Ltd.(NTR)Earnings, Financials & Key Ratios

NTR•NYSE
13.3× P/E·Price updated Jun 19, 2026
SectorBasic MaterialsIndustryAgricultural InputsSub-IndustryAg input retail and farm services
AboutNutrien Ltd. provides crop inputs and services. It offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. The company also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia. In addition, it provides services directly to growers through a network of farm centers in North America, South America, and Australia. The company was founded in 2017 and is headquartered in Saskatoon, Canada.Show more
  • Revenue$27.36B+5.3%
  • EBITDA$6.37B+20.4%
  • Net Income$2.31B+242.2%
  • EPS (Diluted)4.74+248.5%
  • Gross Margin31.05%+7.1%
  • EBITDA Margin23.29%+14.3%
  • Operating Margin14.48%+27.4%
  • Net Margin8.43%+224.9%
  • ROE9.27%+241.4%

NTR Key Insights

Nutrien Ltd. (NTR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y profit CAGR of 38.1%
  • ✓Strong Piotroski F-Score: 8/9
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Healthy dividend yield of 3.5%
  • ✓Trading at only 1.2x book value

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when NTR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

NTR Price & Volume

Nutrien Ltd. (NTR) stock price & volume — 10-year historical chart

Loading chart...

NTR Growth Metrics

Nutrien Ltd. (NTR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years15.86%
5 Years5.52%
3 Years-10.29%
TTM8.1%

Profit CAGR

10 Years6.15%
5 Years38.11%
3 Years-32.97%
TTM353.29%

EPS CAGR

10 Years2.23%
5 Years41.02%
3 Years-29.66%
TTM359.39%

Return on Capital

10 Years8.02%
5 Years13.4%
3 Years8.89%
Last Year9.78%

NTR Recent Earnings

Nutrien Ltd. (NTR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 6, 2026
Metric
Actual
Est
EPS
$0.51+6.3%
$0.48
Rev
$5.7B+7.3%
$5.3B
Q1 2026
Feb 18, 2026
Metric
Actual
Est
EPS
$0.83-4.6%
$0.87
Rev
$5.1B-5.6%
$5.4B
Q4 2025
Nov 5, 2025
Metric
Actual
Est
EPS
$0.97+4.3%
$0.93
Rev
$5.9B+13.2%
$5.2B
Q3 2025
Aug 6, 2025
Metric
Actual
Est
EPS
$2.65+10.4%
$2.40
Rev
$10.4B-0.1%
$10.4B
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 6, 2026
$0.51vs $0.48+6.3%
$5.7Bvs $5.3B+7.3%
Q1 2026Feb 18, 2026
$0.83vs $0.87-4.6%
$5.1Bvs $5.4B-5.6%
Q4 2025Nov 5, 2025
$0.97vs $0.93+4.3%
$5.9Bvs $5.2B+13.2%
Q3 2025Aug 6, 2025
$2.65vs $2.40+10.4%
$10.4Bvs $10.4B-0.1%
Based on last 12 quarters of dataView full earnings history →

NTR Peer Comparison

Nutrien Ltd. (NTR) competitors in Ag input retail and farm services — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
MOS logoMOSThe Mosaic CompanyDirect Competitor7.28B22.9013.478.36%6.03%5.85%0.43
CF logoCFCF Industries Holdings, Inc.Direct Competitor15.81B102.9311.4719.34%23.73%22.29%0.51
ICL logoICLICL Group LtdDirect Competitor6.63B5.1428.564.56%3.52%4.14%0.44
SMG logoSMGThe Scotts Miracle-Gro CompanyDirect Competitor3.75B64.6926.19-3.93%2.68%
AVD logoAVDAmerican Vanguard CorporationProduct Competitor75.81M2.65-1.51-5.88%-8.71%-21.86%0.99
FMC logoFMCFMC CorporationProduct Competitor1.44B11.55-0.65-18.34%-72.93%-82.27%2.00
CTVA logoCTVACorteva, Inc.Product Competitor52.74B78.5649.102.92%6.5%4.62%0.11
UAN logoUANCVR Partners, LPProduct Competitor1.18B111.4011.9415.36%18.89%40.08%2.23

Compare NTR vs Peers

Nutrien Ltd. (NTR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs MOS

Most directly comparable listed peer for NTR.

Scale Benchmark

vs DE

Larger-name benchmark to compare NTR against a more recognizable public peer.

Peer Set

Compare Top 5

vs MOS, CF, ICL, SMG

NTR Income Statement

Nutrien Ltd. (NTR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
4.55B19.64B20.08B20.91B27.71B37.88B29.06B25.97B27.36B27.76B
Revenue Growth %
2.04%331.85%2.28%4.1%32.54%36.71%-23.3%-10.61%5.33%8.1%
Cost of Goods Sold
3.85B14.24B14.58B15.67B18.3B22.46B20.58B18.44B18.86B19.11B
COGS % of Revenue
84.74%72.54%72.61%74.94%66.05%59.29%70.84%71.01%68.95%-
Gross Profit
694M▲ 0%
5.39B▲ 676.9%
5.5B▲ 2.0%
5.24B▼ 4.8%
9.41B▲ 79.6%
15.42B▲ 63.9%
8.47B▼ 45.1%
7.53B▼ 11.1%
8.49B▲ 12.8%
8.66B▲ 0%
Gross Margin %
15.26%27.46%27.39%25.06%33.95%40.71%29.16%28.99%31.05%31.18%
Gross Profit Growth %
-16.39%676.95%2.04%-4.78%79.6%63.93%-45.06%-11.14%12.79%-
Operating Expenses
485M4.98B3.64B4.34B4.63B4.62B4.61B4.58B4.53B4.86B
OpEx % of Revenue
10.67%25.35%18.12%20.74%16.7%12.18%15.88%17.63%16.57%-
Selling, General & Admin
214M2.88B3.01B3.31B3.82B4.09B4.06B4.17B4.15B4.25B
SG&A % of Revenue
4.71%14.65%15%15.84%13.79%10.8%13.99%16.07%15.19%-
Research & Development
0000000000
R&D % of Revenue
----------
Other Operating Expenses
271M2.1B627M1.03B807M523M550M406M378.51M4M
Operating Income
209M▲ 0%
414M▲ 98.1%
1.86B▲ 349.8%
902M▼ 51.6%
4.78B▲ 430.0%
10.81B▲ 126.1%
3.86B▼ 64.3%
2.95B▼ 23.5%
3.96B▲ 34.2%
3.79B▲ 0%
Operating Margin %
4.6%2.11%9.27%4.31%17.25%28.53%13.28%11.36%14.48%13.66%
Operating Income Growth %
-54.47%98.09%349.76%-51.56%430.04%126.08%-64.29%-23.55%34.2%-
EBITDA
901M2.01B3.66B2.89B6.73B12.82B6.03B5.29B6.37B6.19B
EBITDA Margin %
19.82%10.22%18.23%13.83%24.29%33.84%20.75%20.37%23.29%22.3%
EBITDA Growth %
-21.92%122.64%82.5%-21.03%132.86%90.45%-52.98%-12.26%20.43%49.14%
D&A (Non-Cash Add-back)
692M1.59B1.8B1.99B1.95B2.01B2.17B2.34B2.41B2.4B
EBIT
211M431M1.87B903M4.63B10.77B2.72B1.87B3.8B3.93B
Net Interest Income
-238M-538M-554M-520M-466.86M-505.16M-768.85M-634.02M-699.03M-682.49M
Interest Income
2M17M5M1M7.93M24.01M35.64M26.66M00
Interest Expense
240M555M559M521M474.79M529.17M804.49M660.68M699.03M682.49M
Other Income/Expense
-238M-538M-554M-520M-613M-563M-1.91B-1.81B-857.76M-605.61M
Pretax Income
-29M▲ 0%
-124M▼ 327.6%
1.31B▲ 1154.8%
382M▼ 70.8%
4.17B▲ 991.1%
10.25B▲ 145.8%
1.95B▼ 80.9%
1.14B▼ 41.8%
3.1B▲ 173.1%
3.19B▲ 0%
Pretax Margin %
-0.64%-0.63%6.51%1.83%15.04%27.05%6.72%4.37%11.34%11.48%
Income Tax
-183M-93M316M-77M989M2.56B670M436M765.16M768.94M
Effective Tax Rate %
631.03%75%24.16%-20.16%23.73%24.98%34.32%38.38%24.66%24.12%
Net Income
327M▲ 0%
3.57B▲ 992.7%
992M▼ 72.2%
459M▼ 53.7%
3.15B▲ 586.9%
7.66B▲ 142.9%
1.26B▼ 83.6%
674M▼ 46.4%
2.31B▲ 242.2%
2.39B▲ 0%
Net Margin %
7.19%18.2%4.94%2.2%11.38%20.22%4.33%2.6%8.43%8.6%
Net Income Growth %
-2.68%992.66%-72.24%-53.73%586.93%142.94%-83.58%-46.42%242.24%353.29%
Net Income (Continuing)
154M-31M992M459M3.18B7.69B1.28B700M2.34B2.42B
Discontinued Operations
0000000000
Minority Interest
00038M47M45M45M35M41.92M38.13M
EPS (Diluted)
0.98▲ 0%
5.72▲ 483.7%
1.74▼ 69.6%
0.85▼ 51.1%
5.47▲ 543.5%
13.62▲ 149.0%
2.53▼ 81.4%
1.36▼ 46.2%
4.74▲ 248.5%
4.96▲ 0%
EPS Growth %
-2%483.67%-69.58%-51.15%543.53%148.99%-81.42%-46.25%248.53%359.39%
EPS (Basic)
0.985.761.740.855.4913.662.531.364.74-
Diluted Shares Outstanding
336.13M624.9M583.1M569.69M571.29M540.01M496.99M494.37M486.52M481.65M
Basic Shares Outstanding
336.03M620M582.27M569.66M569.66M538.48M496.38M494.37M486.33M481.26M
Dividend Payout Ratio
100.92%26.64%103.02%224.4%33.14%13.46%82.03%157.27%46.8%-

NTR Balance Sheet

Nutrien Ltd. (NTR) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
3.32B11.66B10.66B11.47B13.85B16.34B14.17B13.79B14.72B16.53B
Cash & Short-Term Investments
116M2.31B671M1.45B499M901M941M853M699.72M779.55M
Cash Only
116M2.31B671M1.45B499M901M941M853M699.72M779.55M
Short-Term Investments
0000000000
Accounts Receivable
390M2.75B3.05B3.02B4.71B5.6B4.67B5.39B5.66B6.3B
Days Sales Outstanding
31.3151.0455.3852.761.9753.9258.6475.7575.5891.18
Inventory
788M4.92B4.97B4.93B6.33B7.63B6.34B6.15B6.96B8.71B
Days Inventory Outstanding
74.65126124.53114.84126.19124.03112.36121.68134.76126.72
Other Current Assets
1.96B596M495M607M661M598M730M01.39B735.41M
Total Non-Current Assets
13.68B33.84B36.13B35.72B36.11B38.24B38.58B38.05B37.48B37.57B
Property, Plant & Equipment
12.97B18.8B20.34B19.66B20.02B21.77B22.46B22.6B22.71B22.73B
Fixed Asset Turnover
0.35x1.04x0.99x1.06x1.38x1.74x1.29x1.15x1.20x1.23x
Goodwill
97M11.43B11.99B12.2B12.22B12.37B12.11B12.04B12.11B12.22B
Intangible Assets
69M2.21B2.43B2.39B2.34B2.3B2.22B1.82B1.66B1.63B
Long-Term Investments
292M878M821M562M703M843M736M698M143.74M839.22M
Other Non-Current Assets
228M309M315M672M567M521M574M483M856.44M848.78M
Total Assets
17B▲ 0%
45.5B▲ 167.7%
46.8B▲ 2.9%
47.19B▲ 0.8%
49.95B▲ 5.9%
54.59B▲ 9.3%
52.75B▼ 3.4%
51.84B▼ 1.7%
52.21B▲ 0.7%
54.1B▲ 0%
Asset Turnover
0.27x0.43x0.43x0.44x0.55x0.69x0.55x0.50x0.52x0.53x
Asset Growth %
-1.6%167.69%2.85%0.84%5.85%9.27%-3.37%-1.72%0.71%3%
Total Current Liabilities
1.6B8.34B9.13B8.48B12.44B14.28B12.12B12.04B11.02B13.34B
Accounts Payable
255M3.05B4.02B4.42B5.18B5.8B5.48B5.36B9.29B9.17B
Days Payables Outstanding
24.1678.23100.52102.84103.2894.2197.13106.06179.81131.2
Short-Term Debt
730M1.62B1.48B173M2.1B2.68B2.33B2.57B1.73B4.18B
Deferred Revenue (Current)
0000000000
Other Current Liabilities
438M3.02B2.15B2.31B3.14B3.71B2.6B2.47B00
Current Ratio
2.07x1.40x1.17x1.35x1.11x1.14x1.17x1.15x1.34x1.24x
Quick Ratio
1.58x0.81x0.62x0.77x0.60x0.61x0.65x0.63x0.70x0.59x
Cash Conversion Cycle
81.898.8179.3864.784.8883.7473.8791.3630.5486.7
Total Non-Current Liabilities
7.09B12.74B14.8B16.31B13.81B14.44B15.43B15.35B15.87B15.48B
Long-Term Debt
3.71B7.58B8.55B10.05B7.52B8.04B8.91B8.88B10.27B8.85B
Capital Lease Obligations
012M859M891M934M899M999M999M935.29M3.84B
Deferred Tax Liabilities
2.21B2.91B3.15B3.15B3.17B3.55B3.57B3.54B3.66B10.88B
Other Non-Current Liabilities
1.18B2.24B2.24B2.22B2.19B1.96B1.94B1.93B1B1.95B
Total Liabilities
8.7B21.08B23.93B24.79B26.25B28.72B27.55B27.4B26.89B28.83B
Total Debt
4.44B9.22B11.1B11.36B10.85B11.93B12.57B12.81B12.93B13.99B
Net Debt
4.33B6.91B10.43B9.91B10.35B11.03B11.63B11.95B12.23B13.21B
Debt / Equity
0.53x0.38x0.49x0.51x0.46x0.46x0.50x0.52x0.51x0.55x
Debt / EBITDA
4.93x4.60x3.03x3.93x1.61x0.93x2.08x2.42x2.03x2.26x
Net Debt / EBITDA
4.80x3.44x2.85x3.43x1.54x0.86x1.93x2.26x1.92x2.13x
Interest Coverage
0.88x0.78x3.34x1.73x9.75x20.35x3.38x2.83x5.44x5.76x
Total Equity
8.3B▲ 0%
24.43B▲ 194.2%
22.87B▼ 6.4%
22.4B▼ 2.0%
23.7B▲ 5.8%
25.86B▲ 9.1%
25.2B▼ 2.6%
24.44B▼ 3.0%
25.32B▲ 3.6%
25.27B▲ 0%
Equity Growth %
1.11%194.17%-6.37%-2.04%5.78%9.13%-2.56%-3.01%3.59%9.03%
Book Value per Share
24.7039.0939.2239.3341.4847.8950.7149.4452.0452.48
Total Shareholders' Equity
8.3B24.43B22.87B22.36B23.65B25.82B25.16B24.41B25.28B25.24B
Common Stock
1.81B16.74B15.77B15.67B15.46B14.17B13.84B13.75B13.49B13.56B
Retained Earnings
6.24B7.75B7.1B6.61B8.19B11.93B11.53B11.11B12.05B11.89B
Treasury Stock
0000000000
Accumulated OCI
25M-291M-251M-119M-146M-391M-296M-515M-328.4M-263.87M
Minority Interest
00038M47M45M45M35M41.92M38.13M

NTR Cash Flow Statement

Nutrien Ltd. (NTR) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
1.23B2.05B3.67B3.32B3.89B8.11B5.07B3.54B4.08B4.29B
Operating CF Margin %
26.94%10.45%18.25%15.89%14.02%21.41%17.44%13.61%14.9%-
Operating CF Growth %
-2.78%67.51%78.61%-9.33%16.94%108.7%-37.53%-30.22%15.34%111.51%
Net Income
327M-826M992M459M3.18B7.69B1.28B700M2.31B2.39B
Depreciation & Amortization
692M1.59B1.8B1.99B1.95B2.01B2.17B2.34B2.41B2.4B
Stock-Based Compensation
11M116M104M69M198M63M-14M37M077M
Deferred Taxes
-273M687M177M-9M-31M455M-58M78M254.38M265.23M
Other Non-Cash Items
396M1.62B103M241M250M-959M1.18B868M-97.68M-122.32M
Working Capital Changes
72M-1.14B490M574M-1.66B-1.15B507M-487M-796.71M-725.97M
Change in Receivables
47M-153M-64M145M-1.67B-919M879M-224M-130.24M-447.46M
Change in Inventory
-10M-887M190M85M-1.46B-1.28B1.38B60M03.15B
Change in Payables
00000000-99.72M-117.89M
Cash from Investing
-652M3.89B-2.8B-1.2B-1.81B-2.9B-2.96B-2.13B-1.4B-1.61B
Capital Expenditures
-651M-1.41B-1.73B-1.42B-1.88B-2.48B-2.6B-2.15B-2.04B-2.11B
CapEx % of Revenue
14.32%7.16%8.6%6.81%6.8%6.53%8.95%8.29%7.46%7.62%
Acquisitions
033M-911M-233M-88M-407M-153M-21M-23.4M-61.41M
Investments
----------
Other Investing
-1M5.39B39M14M165M-19M-62M110M-55.96M21.92M
Cash from Financing
-489M-3.71B-2.48B-1.34B-3B-4.73B-2.06B-1.45B-2.87B-2.82B
Debt Issued (Net)
-159M-939M482M-134M-1.1B672M19M-181M-800.78M-955.87M
Equity Issued (Net)
1M-1.79B-1.91B-160M-835M-4.35B-1.01B-166M-521.98M-469.68M
Dividends Paid
-330M-952M-1.02B-1.03B-1.04B-1.03B-1.03B-1.06B-1.08B-1.06B
Share Repurchases
0-1.8B-1.93B-160M-1.03B-4.52B-1.05B-184M-560.65M-548.97M
Other Financing
-1M-21M-29M-15M-21M-20M-34M-46M-463.98M-339.48M
Net Change in Cash
84M▲ 0%
2.2B▲ 2516.7%
-1.64B▼ 174.7%
783M▲ 147.7%
-955M▼ 222.0%
402M▲ 142.1%
40M▼ 90.0%
-88M▼ 320.0%
-152.77M▼ 73.6%
-118.53M▲ 0%
Free Cash Flow
574M▲ 0%
545M▼ 5.1%
1.77B▲ 225.5%
1.77B▲ 0.0%
2B▲ 12.9%
5.63B▲ 181.5%
2.47B▼ 56.2%
1.38B▼ 44.0%
2.04B▲ 47.5%
2.23B▲ 0%
FCF Margin %
12.62%2.78%8.83%8.48%7.22%14.87%8.49%5.32%7.45%8.04%
FCF Growth %
56.4%-5.05%225.5%0%12.85%181.47%-56.24%-44%47.51%153.51%
FCF per Share
1.710.873.043.113.5010.434.962.794.194.63
FCF Conversion (FCF/Net Income)
3.75x0.57x3.69x7.24x1.23x1.06x4.03x5.24x1.77x0.93x
Interest Paid
198M507M505M498M491M482M729M740M0220M
Taxes Paid
83M1.16B29M156M435M1.88B1.76B321M00

NTR Key Ratios

Nutrien Ltd. (NTR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
3.96%21.83%4.2%2.03%13.68%30.91%4.93%2.72%9.27%9.47%
Return on Invested Capital (ROIC)
1.23%1.41%4.32%2.06%10.81%22.86%7.85%6.05%8.03%7.48%
Gross Margin
15.26%27.46%27.39%25.06%33.95%40.71%29.16%28.99%31.05%31.18%
Net Margin
7.19%18.2%4.94%2.2%11.38%20.22%4.33%2.6%8.43%8.6%
Debt / Equity
0.53x0.38x0.49x0.51x0.46x0.46x0.50x0.52x0.51x0.55x
Interest Coverage
0.88x0.78x3.34x1.73x9.75x20.35x3.38x2.83x5.44x5.76x
FCF Conversion
3.75x0.57x3.69x7.24x1.23x1.06x4.03x5.24x1.77x0.93x
Revenue Growth
2.04%331.85%2.28%4.1%32.54%36.71%-23.3%-10.61%5.33%8.1%
Related:NTR Dividend History·NTR Revenue History·NTR Price History·NTR P/E History·NTR Financial Ratios·NTR Institutional Holders

NTR Frequently Asked Questions

Nutrien Ltd. (NTR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Nutrien Ltd. (NTR) reported $27.76B in revenue for fiscal year 2025. This represents a 1878% increase from $1.40B in 1996.

Nutrien Ltd. (NTR) grew revenue by 5.3% over the past year. This is steady growth.

Yes, Nutrien Ltd. (NTR) is profitable, generating $2.39B in net income for fiscal year 2025 (8.4% net margin).

Dividend & Returns

Yes, Nutrien Ltd. (NTR) pays a dividend with a yield of 3.53%. This makes it attractive for income-focused investors.

Nutrien Ltd. (NTR) has a return on equity (ROE) of 9.3%. This is below average, suggesting room for improvement.

Nutrien Ltd. (NTR) generated $2.23B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in NTR back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →

How much would $100/month in NTR be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →